Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)

Phase 2

Completed

Conditions: Lung Cancer
Non Small Cell Lung Cancer

Interventions: Drug: erlotinib
Drug: Pemetrexed
Drug: Cisplatin
Procedure: Resection

First Posted Date: 2007-12-20

Last Posted Date: 2018-01-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT00577707

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Internet-based System for Cancer Patients to Self-report Toxicity

Not Applicable

Completed

Conditions: Cervical Cancer
Vaginal Cancer
Bladder Cancer
Lung Cancer
Prostate Cancer
Breast Cancer
Ovarian Cancer

Interventions: Behavioral: Questioners
Behavioral: STAR website

First Posted Date: 2007-12-20

Last Posted Date: 2017-01-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1007

Registration Number: NCT00578006

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Breast MRI Spectroscopy

Not Applicable

Completed

Conditions: Suspicion of, or Known Breast Cancer

Interventions: Other: Radiology/MRI scan

First Posted Date: 2007-12-20

Last Posted Date: 2016-11-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 150

Registration Number: NCT00577915

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical Prostatectomy

Not Applicable

Completed

Conditions: Quality of Life
Prostate Cancer

Interventions: Behavioral: Quality of Life Questionnaires

First Posted Date: 2007-12-20

Last Posted Date: 2022-06-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 959

Registration Number: NCT00578123

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans

Completed

Conditions: HIV Infections
Mental Health

First Posted Date: 2007-12-20

Last Posted Date: 2009-01-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 628

Registration Number: NCT00577811

Locations: 🇺🇸
Memorial Slaon-Kettering Cancer Center, New York, New York, United States

Reconstructive Surgery For Head And Neck Cancer Patients

Completed

Conditions: Advanced Stage Head and Neck Cancer

First Posted Date: 2007-12-20

Last Posted Date: 2017-10-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 80

Registration Number: NCT00578032

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Assessment of the Functional Significance of Accessory Pudendal Arteries

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Procedure: Trimix Injection with Doppler Ultrasound

First Posted Date: 2007-12-20

Last Posted Date: 2011-10-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 38

Registration Number: NCT00577876

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Propofol's Hypnotic and Memory Effects

Completed

Conditions: Healthy

Interventions: Drug: Placebo solution
Drug: propofol

First Posted Date: 2007-12-19

Last Posted Date: 2016-05-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 102

Registration Number: NCT00576615

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Smoking Cessation Intervention for Cancer Patients

Not Applicable

Active, not recruiting

Conditions: Newly Diagnosed Cancer Patients

Interventions: Behavioral: Hospital Counseling + Nicotine Replacement Therapy. questionaires
Behavioral: Hospital Counseling + Nicotine Replacement + Presurgical Scheduled Reduced Smoking, questionaires

First Posted Date: 2007-12-18

Last Posted Date: 2024-10-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 204

Registration Number: NCT00575718

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Drug: cyclophosphamide
Drug: cyclosporine
Drug: fludarabine phosphate
Drug: gemcitabine hydrochloride
Drug: ifosfamide
Drug: mechlorethamine hydrochloride
Drug: melphalan
Drug: methotrexate
Drug: mycophenolate mofetil
Drug: prednisone
Drug: procarbazine hydrochloride
Drug: vincristine sulfate
Drug: vinorelbine tartrate
Procedure: allogeneic bone marrow transplantation
Procedure: allogeneic hematopoietic stem cell transplantation
Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
Procedure: peripheral blood stem cell transplantation
Procedure: umbilical cord blood transplantation
Radiation: total-body irradiation

First Posted Date: 2007-12-17

Last Posted Date: 2023-09-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT00574496

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Home Terms & Conditions Privacy Policy